Trials / Completed
CompletedNCT03137797
Cohort of Patients Naive of Antiretroviral Treatment at Enrollment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 800 (actual)
- Sponsor
- ANRS, Emerging Infectious Diseases · Other Government
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the short, medium and long-term prognosis for newly diagnosed HIV patients.
Detailed description
The purpose of this study is to evaluate the short, medium and long-term prognosis for newly diagnosed HIV patients. This study aims to precise the impact of HIV infection treatment on morbidity and mortality, the factors related to treatment response, clinical and biological complications, their consequences, especially lipodystrophy and metabolic abnormalities, associated factors especially genetic, aspects linked to aging. In addition, the study describes the evolution of patients living conditions and behaviors remotely from their screening, particularly related to sexuality, reproduction, and health inequalities and to study the long-term treatment adherence. One third of the patients were included in the metabolic disorders module. This module includes additional biological and imaging explorations.
Conditions
Timeline
- Start date
- 2004-02-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2017-05-03
- Last updated
- 2017-05-03
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03137797. Inclusion in this directory is not an endorsement.